Table 3.
The contribution of profile variation in explaining peritraumatic stress symptoms since the outbreak of the COVID-19 pandemic (n = 849)
| Peritraumatic intrusion symptoms |
Peritraumatic avoidance symptoms |
Peritraumatic negative alterations in mood and cognition |
Peritraumatic hyperarousal symptoms |
|||||
|---|---|---|---|---|---|---|---|---|
| F | η2p | F | η2p | F | η2p | F | η2p | |
| Age | 2.79 (1, 838) | .00 | 4.92* (1, 838) | .01 | 19.81*** (1, 838) | .02 | 19.71*** (1, 838) | .02 |
| Gender | 3.24 (1, 838) | .00 | .10 (1, 838) | .00 | .16 (1, 838) | .00 | .68 (1, 838) | .00 |
| Income | 2.15 (1, 838) | .00 | 6.24* (1, 838) | 01 | 9.20** (1, 838) | .01 | 6.30* (1, 838) | .01 |
| Perceived health | 14.03*** (1, 838) | .02 | 3.90* (1, 838) | .01 | 16.58*** (1, 838) | .02 | 12.32*** (1, 838) | .01 |
| Belong/don’t belong to risk group | 4.25* (1, 838) | .01 | 3.37 (1, 838) | .00 | .23 (1, 838) | 00 | 2.49 (1, 838) | .00 |
| Profile type | 54.06*** (2, 838) | .11 | 40.61*** (2, 838) | .09 | 96.52*** (2, 838) | .19 | 100.94*** (2, 838) | .19 |
*p < .05; ** p < .01; *** p < .001.